Go Pro
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel Free MOTS Stock Alerts

Motus GI (MOTS) Competitors

Motus GI logo
$0.0002 0.00 (0.00%)
As of 09/18/2026
Compare

MOTS vs. AFIB, UTRS, DRTSW, BDMDW, and COCHW

Should you buy Motus GI stock or one of its competitors? Motus GI's main competitors and comparable companies include Acutus Medical (AFIB), Minerva Surgical (UTRS), Alpha Tau Medical (DRTSW), Baird Medical Investment (BDMDW), and Envoy Medical (COCHW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Motus GI compare to Acutus Medical?

Motus GI (NASDAQ:MOTS) and Acutus Medical (NASDAQ:AFIB) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation, risk and media sentiment.

Motus GI has a beta of 0.81, suggesting that its share price is 19% less volatile than the broader market. Comparatively, Acutus Medical has a beta of 5.73, suggesting that its share price is 473% more volatile than the broader market.

Motus GI has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Motus GI's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

Motus GI has higher earnings, but lower revenue than Acutus Medical. Motus GI is trading at a lower price-to-earnings ratio than Acutus Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

20.1% of Motus GI shares are held by institutional investors. Comparatively, 56.9% of Acutus Medical shares are held by institutional investors. 0.3% of Motus GI shares are held by insiders. Comparatively, 5.2% of Acutus Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Motus GI's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
Motus GI Neutral
Acutus Medical Neutral

Summary

Motus GI and Acutus Medical tied by winning 5 of the 10 factors compared between the two stocks.

How does Motus GI compare to Minerva Surgical?

Minerva Surgical (NASDAQ:UTRS) and Motus GI (NASDAQ:MOTS) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk.

Minerva Surgical has a beta of 2.41, meaning that its share price is 141% more volatile than the broader market. Comparatively, Motus GI has a beta of 0.81, meaning that its share price is 19% less volatile than the broader market.

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled Motus GI'saverage media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
Motus GI Neutral

Motus GI has lower revenue, but higher earnings than Minerva Surgical. Motus GI is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A
Motus GI$319K0.00-$12.87M-$14.69N/A

20.1% of Motus GI shares are owned by institutional investors. 8.5% of Minerva Surgical shares are owned by company insiders. Comparatively, 0.3% of Motus GI shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Motus GI N/A N/A N/A

Summary

Minerva Surgical beats Motus GI on 4 of the 7 factors compared between the two stocks.

How does Motus GI compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and Motus GI (NASDAQ:MOTS) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
Motus GI N/A N/A N/A

In the previous week, Alpha Tau Medical's average media sentiment score of 0.21 beat Motus GI's score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the media.

Company Overall Sentiment
Alpha Tau Medical Neutral
Motus GI Neutral

20.1% of Motus GI shares are held by institutional investors. 0.3% of Motus GI shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Alpha Tau Medical has higher earnings, but lower revenue than Motus GI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
Motus GI$319K0.00-$12.87M-$14.69N/A

Summary

Motus GI beats Alpha Tau Medical on 3 of the 4 factors compared between the two stocks.

How does Motus GI compare to Baird Medical Investment?

Motus GI (NASDAQ:MOTS) and Baird Medical Investment (NASDAQ:BDMDW) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment and risk.

20.1% of Motus GI shares are held by institutional investors. 0.3% of Motus GI shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Baird Medical Investment N/A N/A N/A

In the previous week, Motus GI's average media sentiment score of 0.00 equaled Baird Medical Investment'saverage media sentiment score.

Company Overall Sentiment
Motus GI Neutral
Baird Medical Investment Neutral

Baird Medical Investment has higher revenue and earnings than Motus GI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Baird Medical Investment$24.49MN/AN/AN/AN/A

Summary

Motus GI beats Baird Medical Investment on 2 of the 3 factors compared between the two stocks.

How does Motus GI compare to Envoy Medical?

Envoy Medical (NASDAQ:COCHW) and Motus GI (NASDAQ:MOTS) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

In the previous week, Envoy Medical's average media sentiment score of 0.00 equaled Motus GI'saverage media sentiment score.

Company Overall Sentiment
Envoy Medical Neutral
Motus GI Neutral

20.1% of Motus GI shares are held by institutional investors. 0.3% of Motus GI shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Envoy MedicalN/A N/A N/A
Motus GI N/A N/A N/A

Envoy Medical has higher earnings, but lower revenue than Motus GI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envoy Medical$207KN/AN/AN/AN/A
Motus GI$319K0.00-$12.87M-$14.69N/A

Summary

Motus GI beats Envoy Medical on 3 of the 3 factors compared between the two stocks.

Get Motus GI News Delivered to You Automatically

Sign up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MOTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MOTS vs. The Competition

Export
MetricMotus GIHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1K$5.49B$7.22B$12.94B
Dividend YieldN/A1.80%2.57%12.80%
P/E Ratio0.0025.34275.5125.40
Price / Sales0.0072.58630.0278.28
Price / CashN/A33.1128.1334.74
Price / Book0.005.9010.506.32
Net Income-$12.87M$151.55M$3.49B$358.20M
7 Day PerformanceN/A0.18%-0.25%0.42%
1 Month PerformanceN/A-3.87%-2.69%-3.30%
1 Year PerformanceN/A6.79%18.14%5.33%

Motus GI Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MOTS
Motus GI
N/A$0.00
flat		N/AN/A$1K$319KN/A15
AFIB
Acutus Medical
N/AN/AN/AN/A$3K$7.16MN/A340
UTRS
Minerva Surgical
N/AN/AN/AN/A$1K$51.69MN/A160
DRTSW
Alpha Tau Medical
N/A$4.16
+3.0%		N/A+1,230.3%$0.00N/AN/A80
BDMDW
Baird Medical Investment
N/A$0.04
flat		N/AN/A$0.00$24.49MN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:MOTS) was last updated on 9/21/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel